文献速递腹部介入CT

肝射频消融术后胃肠道并发症:CT预测主要并发症

Gastrointestinal tract complications after hepatic radiofrequency ablation: CT prediction for major complications.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

回顾性分析2005年1月至2016年9月3933例肝恶性肿瘤射频消融患者中52例(1.32%)胃肠道并发症的CT特征,其中主要并发症2例(0.05%)、次要并发症50例(1.27%);主要并发症组肠壁增厚更厚(1.8 vs. 1.1 cm)且更多呈同心圆状(2/2,100% vs. 1/50,2.0%)伴黏膜不连续(2/2,100% vs. 0/50,0%)(P < 0.05)。结论认为CT上>1.65 cm厚、同心圆状肠壁增厚伴黏膜破坏可能提示需手术的主要胃肠道损伤。

要点

  • 肝RFA后胃肠道并发症罕见(52/3933,1.32%),多数可保守治疗。
  • 主要并发症CT征象:肠壁增厚>1.65 cm、同心圆状增厚、黏膜不连续。
  • 损伤最常见部位为胃(28/52,53.8%),其次结肠(17/52,32.7%)。

核心结论

  • 肝RFA后胃肠道并发症罕见且常需保守治疗,但CT显示>1.65 cm厚、同心圆状肠壁增厚伴黏膜破坏的患者可能存在需肠道手术的主要胃肠道损伤。

研究设计与样本

  • 回顾性研究,纳入2005年1月至2016年9月3933例肝恶性肿瘤RFA患者中52例(1.32%)发生胃肠道并发症者,复习电子病历和CT结果,按保守治疗恢复(次要组)与需手术(主要组)分组比较。

关键影像表现/征象

  • 47/52(90.4%)肿瘤位于包膜下,66%位于左肝叶。
  • 损伤器官:胃28/52(53.8%)、结肠17/52(32.7%)、小肠7/52(13.5%)。
  • 主要并发症组肠壁增厚1.8 cm vs. 次要组1.1 cm。
  • 主要并发症组同心圆状肠壁增厚2/2(100%)vs. 次要组1/50(2.0%)。
  • 主要并发症组黏膜不连续2/2(100%)vs. 次要组0/50(0%)。

诊断标准与关键数值

  • CT预测主要胃肠道并发症的肠壁厚度阈值为>1.65 cm。
  • 主要并发症组肠壁增厚1.8 cm vs. 次要组1.1 cm(P < 0.05)。
  • 同心圆状肠壁增厚主要组2/2(100%)vs. 次要组1/50(2.0%)(P < 0.05)。
  • 黏膜不连续主要组2/2(100%)vs. 次要组0/50(0%)(P < 0.05)。

临床应用与阅片要点

  • 肝RFA后CT评估胃肠道并发症时,应关注肠壁厚度、增厚形态(同心圆状)及黏膜连续性。
  • 肠壁增厚>1.65 cm、同心圆状增厚伴黏膜不连续可能提示需手术的主要胃肠道损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To analyze CT features that predict major gastrointestinal tract (GIT) complication after hepatic radiofrequency ablation (RFA).

MATERIALS AND METHODS: Of 3933 patients who underwent RFA for hepatic malignancy from January 2005 to September 2016, 52 patients (1.32%) who had GIT complications were retrospectively enrolled. Electronic medical records and CT results were reviewed for location (left vs. right lobe, subcapsular vs. non-subcapsular) and tumor size, distance from the hepatic capsule, number and length of needles, ablation time, presence of artificial ascites, previous history of percutaneous treatment or operation, injured organs, length and thickness of injured GIT, presence of adjacent infiltration, ascites, mucosal discontinuity, and free air, and eccentricity. Patients were divided into those that recovered with conservative treatment (minor group) and those that required operation (major group). Chi-square test, Fisher's exact test, and Mann-Whitney U test analyzed differences between the two groups; however, the most significant variable was found using binary logistic regression analysis.

RESULTS: Of 52 patients who had GIT complications after hepatic RFA, 2 patients (0.05%) had major GIT complications, while the remaining 50 patients (1.27%) had minor complications. Most (47/52, 90.4%) of the tumors were located at subcapsular portion. 66% of tumors were located at the left hepatic lobe. Stomach was the most frequent injured organ (28/52, 53.8%), followed by colon (17/52, 32.7%) and small bowel (7/52, 13.5%). Patients with major GIT complications had significantly thicker (1.8 vs. 1.1 cm) and concentric (2/2, 100% vs. 1/50, 2.0%) bowel wall thickening with mucosal discontinuity (2/2, 100% vs. 0/50, 0%) than those with minor complications (P < 0.05).

CONCLUSION: GIT complication after hepatic RFA is rare and often requires conservative treatment. However, patients who show >1.65-cm-thick, concentric bowel wall thickening with mucosal disruption on CT after hepatic RFA may have major GIT injury that requires bowel surgery.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Jeong YS, Kim SH, Lee JM, et al. Gastrointestinal tract complications after hepatic radiofrequency ablation: CT prediction for major complications. Abdom Radiol (NY). 2018. PMID: 28676999. doi:10.1007/s00261-017-1239-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。